Tag Archives: Hillary Clinton

Obamacare startup Oscar racks up $45-million 3Q Loss; Trump’s healthcare agenda meddling with in-law’s $2.7-billion bet

Oscar Insurance Corp. (New York City), the Silicon Valley-backed healthcare startup, continued to lose tens of millions of dollars in the third quarter as the company exits some markets and works… Read more »

Trump win sends pharma stocks up, while hospitals plunge; fate of Obamacare far from clear

Pharmaceutical stocks and bonds were among the day’s biggest winners Wednesday (November 9, 2016) as the sweeping Republican victory in US elections eased concern that price controls might be imposed… Read more »

Pharma stocks dive on price-fixing probes; better days for healthcare sector uncertain no matter who’s in the White House

The generic drug industry was jolted last week as shares of many major companies tumbled after a news report said that a federal inquiry into drug price-fixing was wider than… Read more »

Cempra stock tanks on FDA concerns for lead drug’s side-effects; high hopes still riding on Friday AdCom meeting

Cempra Inc.’s (Chapel Hill NC) experimental drug to treat community-acquired pneumonia, the kind recently suffered by presidential candidate Hillary Clinton, causes a potentially concerning rise in liver enzymes, according to… Read more »

Ariad Pharma’s Slide Continues as Bernie Sanders Seeks Data on Leukemia Drug; Recent Drug Price Hikes Put Company on Familiar Hot Seat

Ariad Pharmaceuticals Inc. (Cambridge MA) continued to plummet Thursday (October 20, 2016) after Vermont Sen. Bernie Sanders and Maryland Rep. Elijah Cummings sent a letter to the company, demanding more information about… Read more »

Healthcare Stocks Tumble as Clinton’s Lead Widens; Are the Jitters Justified or Do Opportunities Abound?

Democratic presidential nominee Hillary Clinton has been named the culprit for beating down biotech stocks just for squealing about high drug prices on Twitter. Imagine the ever-increasing likelihood of her becoming the… Read more »

Government to Pick Plans for Displaced Health Law Customers; Bill Clinton Weighs In on Obamacare Shortcomings

The insurance markets were envisioned as dynamic engines of private competition. But in many states, they have run into problems. Worried that insurers bailing out of the health law’s markets… Read more »

Trump’s Prospects Starting to Stir as Clinton’s Health Remains a Question

Hillary Clinton’s personal health scare is a new market risk for jittery investors already spooked by central banks poised to disappear into the woodwork in the face of lax money policies. The 68-year-old Democratic… Read more »

Mylan Plans Generic EpiPen to Calm Pricing Outrage; Feels More Like a PR Move

Mylan NV’s latest attempt to deflect criticism over the price of allergy shot EpiPen failed to get the drugmaker out of the crosshairs of Congress this week. Last week, Chief… Read more »